Biogen, Inc. (BIIB)
172.97
-4.14
(-2.34%)
USD |
NASDAQ |
Apr 10, 16:00
173.10
+0.13
(+0.08%)
After-Hours: 20:00
Biogen Free Cash Flow : 1.969B for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.10B |
| Gilead Sciences, Inc. | 9.456B |
| Johnson & Johnson | 19.70B |
| Apellis Pharmaceuticals, Inc. | 45.01M |
| Moderna, Inc. | -2.075B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 511.90M |
| Cash from Investing (Quarterly) | -1.232B |
| Cash from Financing (Quarterly) | -137.00M |
| Free Cash Flow Per Share (Quarterly) | 2.738 |
| Free Cash Flow to Equity (Quarterly) | 334.20M |
| Free Cash Flow to Firm (Quarterly) | 460.64M |
| Free Cash Flow Yield | 7.76% |